Back to top

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW251, a Novel ...

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW251, a Novel Glypican 3-Targeted Topoisomerase 1 Inhibitor Antibody-Drug Conjugate | ZYME Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Zymeworks Inc. (ZYME)